Jazz Income Quality from 2010 to 2024

JAZZ Stock  USD 119.08  7.53  6.75%   
Jazz Pharmaceuticals Income Quality yearly trend continues to be fairly stable with very little volatility. Income Quality will likely drop to 1.36 in 2024. Income Quality is an assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure. View All Fundamentals
 
Income Quality  
First Reported
2010-12-31
Previous Quarter
2.63240782
Current Value
1.36
Quarterly Volatility
2.73061194
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 368.7 M, Other Operating Expenses of 3.3 B or Operating Income of 692.2 M, as well as many indicators such as Price To Sales Ratio of 1.93, Dividend Yield of 0.0 or PTB Ratio of 2.98. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Income Quality Growth Pattern

Below is the plot of the Income Quality of Jazz Pharmaceuticals PLC over the last few years. It is an assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure. Jazz Pharmaceuticals' Income Quality historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Income Quality10 Years Trend
Pretty Stable
   Income Quality   
       Timeline  

Jazz Income Quality Regression Statistics

Arithmetic Mean1.24
Geometric Mean1.84
Coefficient Of Variation220.24
Mean Deviation1.54
Median1.42
Standard Deviation2.73
Sample Variance7.46
Range12.7552
R-Value(0.25)
Mean Square Error7.51
R-Squared0.06
Significance0.36
Slope(0.16)
Total Sum of Squares104.39

Jazz Income Quality History

2024 1.36
2023 2.63
2022 -5.68
2021 -2.36
2020 3.77
2019 1.48
2018 1.79

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Income Quality, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Quality 2.63  1.36 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.